Committee approves bill allowing pharmacists to fill noncontrolled prescriptions after a prescriber's death

House Bill 501, introduced by state Representatives Mitch Whitaker and Derek Lewis, passed the Committee on Health Services unanimously after sponsors described the bill as a continuity‑of‑care measure for patients of deceased prescribers.

The bill allows prescriptions written by a health care provider who has died to be filled for a determined period after the provider’s death, with an explicit exclusion for controlled substances to comply with federal law. Sponsors told the committee the bill is intended to remove uncertainty and potential legal liability for pharmacists when they learn a prescriber has died.

Representative Mitch Whitaker, sponsor, described HB 501 as a continuity provision. “House Bill 501 provides continuity of care when a patient's health care provider dies by allowing the prescription to be filled for a determined period after the death,” Whitaker told the committee.

Representative Derek Lewis, co‑sponsor, described a real‑world incident that motivated the bill: a nurse practitioner in his area died in a traffic accident, and pharmacies and providers were unsure whether previously written prescriptions and refills could legally be filled. Lewis recounted contacting the Kentucky Board of Pharmacy and finding no clear rule: “They were like, well, you know, really, we don't have anything on the books.” He said the legislation was drafted in coordination with the Board of Pharmacy and with attention to not conflicting with DEA rules for scheduled drugs.

Committee members asked about documentation and verification requirements. Lewis said the bill applies only when the pharmacist is aware of the provider’s death; it does not impose a duty on pharmacists to independently verify a practitioner’s status. He said, in his pharmacies, staff typically note the provider’s death on the hard‑copy prescription and scan that notation into the system.

Lewis also said that retail and specialty pharmacists who consulted on the draft had experienced similar incidents and expressed support; representatives from the Kentucky Pharmacists Association had reviewed the draft and indicated support with suggested simplifications to be discussed later.

The clerk took a roll call; the transcript records 13 recorded affirmative votes on HB 501 in committee and the chair announced the bill passed with favorable expression. No amendments were recorded in committee testimony.

Why it matters: The bill aims to reduce legal uncertainty for pharmacists and preserve access to ongoing therapy for patients whose prescribers die, while explicitly excluding controlled substances consistent with federal law.

Next steps: Committee reported HB 501 favorably. Sponsors said they will continue discussions with pharmacy stakeholders and board staff on technical clarifications.

Speakers quoted or who spoke on the record in committee included Representative Mitch Whitaker and Representative Derek Lewis.